1Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin, 1999, 49 (1): 33-64.
2Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in aded gastric cancer: a systematic review and Meta- analysis d on aggregate data. J Clin Oncol, 2006, 24 (18) : 2903-2909.
3Cullinan SA, Moertel CG, Fleming TR, et al. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. JAMA, 1985, 253 (14): 2061-2067.
4Kim NK, Park YS, Heo DS, et al. A phase Ⅲ randomized study of 5 - fluorouracil and cisplatin versus 5 - fluorouracil doxorubicin, and mitomycin C versus 5 - fluorouracil alone in the treatment of advanced gastric cancer. Cancer, 1993, 71 (12) 3813-3818.
5Wils JA, Klein HO, Wagener D J, et al. Sequential high - dose methotrexate and fluorouracil combined with doxorubicin - - a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol, 1991, 9 (5) : 827-831.
6Rougier P, Wilke H, et al. Final results of a randomized phase Ⅲ trial of sequential high - dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol, 2000, 18 (14): 2648-2657.
7Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol, 1997, 15 (1): 261-267.
8Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first - line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol, 2006, 24 (31): 4991-4997.
9Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med, 2008, 358 (1): 36- 46.
10Park SH, Lee WK, Chung M, et al. Paclitaxel versus docetaxgastric cancer: a randomized phase Ⅱ trial in combination with infusional 5 - fluorouracil. Anticancer Drugs 2006, 17 (2): 225-229.
